Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Short Interest Update

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) was the recipient of a large increase in short interest during the month of January. As of January 15th, there was short interest totaling 983,500 shares, an increase of 226.6% from the December 31st total of 301,151 shares. Based on an average daily trading volume, of 1,580 shares, the days-to-cover ratio is currently 622.5 days. Based on an average daily trading volume, of 1,580 shares, the days-to-cover ratio is currently 622.5 days.

Shanghai Fosun Pharmaceutical (Group) Stock Performance

Shanghai Fosun Pharmaceutical (Group) stock opened at $2.86 on Thursday. The stock has a 50-day moving average of $3.00 and a two-hundred day moving average of $2.92. Shanghai Fosun Pharmaceutical has a one year low of $1.62 and a one year high of $3.50.

About Shanghai Fosun Pharmaceutical (Group)

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.